These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19591221)

  • 1. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy.
    Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Hardt S; Goeser S; Kaya Z; Katus HA; Dengler TJ
    J Clin Apher; 2009; 24(4):141-9. PubMed ID: 19591221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy.
    Staudt A; Staudt Y; Hummel A; Empen K; Dörr M; Trimpert C; Birkenmeier K; Kühl U; Noutsias M; Russ D; Felix SB
    Ther Apher Dial; 2006 Feb; 10(1):42-8. PubMed ID: 16556135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption.
    Staudt A; Dörr M; Staudt Y; Böhm M; Probst M; Empen K; Plötz S; Maschke HE; Hummel A; Baumann G; Felix SB
    Am Heart J; 2005 Oct; 150(4):729-36. PubMed ID: 16209975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study to assess the use of protein a immunoadsorption for chronic dilated cardiomyopathy.
    Cooper LT; Belohlavek M; Korinek J; Yoshifuku S; Sengupta PP; Burgstaler EA; Winters JL
    J Clin Apher; 2007; 22(4):210-4. PubMed ID: 17385721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy.
    Herda LR; Trimpert C; Nauke U; Landsberger M; Hummel A; Beug D; Kieback A; Dörr M; Empen K; Knebel F; Ewert R; Angelow A; Hoffmann W; Felix SB; Staudt A
    Am Heart J; 2010 May; 159(5):809-16. PubMed ID: 20435190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of protein A immunoadsorption in patients with chronic dilated cardiomyopathy.
    Doesch AO; Mueller S; Konstandin M; Celik S; Kristen A; Frankenstein L; Goeser S; Kaya Z; Zugck C; Dengler TJ; Katus HA
    J Clin Apher; 2010; 25(6):315-22. PubMed ID: 20824621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy.
    Knebel F; Böhm M; Staudt A; Borges AC; Tepper M; Jochmann N; Wernicke KD; Felix S; Baumann G
    Int J Cardiol; 2004 Dec; 97(3):517-20. PubMed ID: 15561342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy.
    Doesch AO; Mueller S; Nelles M; Konstandin M; Celik S; Frankenstein L; Goeser S; Kaya Z; Koch A; Zugck C; Katus HA
    Basic Res Cardiol; 2011 Jan; 106(1):25-35. PubMed ID: 20957484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a repeated immunoadsorption in patients with dilated cardiomyopathy after recurrence of severe heart failure symptoms.
    Reinthaler M; Empen K; Herda LR; Schwabe A; Rühl M; Dörr M; Felix SB
    J Clin Apher; 2015 Aug; 30(4):217-23. PubMed ID: 25346275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy.
    Bielecka-Dabrowa A; Goch JH; Mikhailidis DP; Rysz J; Maciejewski M; Banach M
    Med Sci Monit; 2009 Dec; 15(12):MS12-23. PubMed ID: 19946241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry.
    Ohlow MA; Brunelli M; Schreiber M; Lauer B
    J Cardiol; 2017 Feb; 69(2):409-416. PubMed ID: 27890513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy.
    Miettinen KH; Eriksson S; Magga J; Tuomainen P; Kuusisto J; Vanninen EJ; Turpeinen A; Punnonen KR; Pettersson K; Peuhkurinen KJ
    J Card Fail; 2008 Aug; 14(6):481-8. PubMed ID: 18672196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantigen estimation and simple screening assay against cardiodepressant autoantibodies in patients with dilated cardiomyopathy.
    Baba A
    Ther Apher Dial; 2008 Apr; 12(2):109-16. PubMed ID: 18387158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific immunoadsorption therapy using a tryptophan column in patients with refractory heart failure due to dilated cardiomyopathy.
    Nagatomo Y; Baba A; Ito H; Naito K; Yoshizawa A; Kurita Y; Nakamura I; Monkawa T; Matsubara T; Wakabayashi Y; Ogawa S; Akaishi M; Yoshikawa T
    J Clin Apher; 2011; 26(1):1-8. PubMed ID: 21312253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
    Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R
    Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.
    Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R
    Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
    Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between NT-proBNP values and changes in functional capacity in patients with chronic heart failure.
    Fernandes R; Feliciano J; Soares RM; Mamede A; Ramos R; Miranda F; Silva S; Timóteo AT; Abreu A; Ferreira R
    Rev Port Cardiol; 2007 Dec; 26(12):1329-44. PubMed ID: 18338663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fcgamma-receptor IIa polymorphism and the role of immunoadsorption in cardiac dysfunction in patients with dilated cardiomyopathy.
    Staudt A; Herda LR; Trimpert C; Lubenow L; Landsberger M; Dörr M; Hummel A; Eckerle LG; Beug D; Müller C; Hoffmann W; Weitmann K; Klingel K; Kandolf R; Kroemer HK; Greinacher A; Felix SB
    Clin Pharmacol Ther; 2010 Apr; 87(4):452-8. PubMed ID: 20054293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Cardiac Biomarkers for Monitoring Improvement of Left Ventricular Function by Immunoadsorption Treatment in Dilated Cardiomyopathy.
    Weinmann K; Werner J; Koenig W; Rottbauer W; Walcher D; Keßler M
    Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31731547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.